Cargando…

Electrostatic Modifications of the Human Leukocyte Antigen-DR P9 Peptide-Binding Pocket and Susceptibility to Primary Sclerosing Cholangitis

The strongest genetic risk factors for primary sclerosing cholangitis (PSC) are found in the human leukocyte antigen (HLA) complex at chromosome 6p21. Genes in the HLA class II region encode molecules that present antigen to T lymphocytes. Polymorphisms in these genes are associated with most autoim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hov, Johannes R, Kosmoliaptsis, Vasilis, Traherne, James A, Olsson, Marita, Boberg, Kirsten M, Bergquist, Annika, Schrumpf, Erik, Bradley, J Andrew, Taylor, Craig J, Lie, Benedicte A, Trowsdale, John, Karlsen, Tom H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Subscription Services, Inc., A Wiley Company 2011
Materias:	Autoimmune, Cholestatic and Biliary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128712/ https://www.ncbi.nlm.nih.gov/pubmed/21413052 http://dx.doi.org/10.1002/hep.24299

Ejemplares similares

Serum Immunoglobulin G4 and Immunoglobulin G1 for Distinguishing Immunoglobulin G4-Associated Cholangitis From Primary Sclerosing Cholangitis
por: Boonstra, Kirsten, et al.
Publicado: (2014)

Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2‐deficient mice
por: Zhou, Mei, et al.
Publicado: (2016)

Immunoglobulin G4(+) B‐cell receptor clones distinguish immunoglobulin G 4‐related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies
por: Doorenspleet, Marieke E., et al.
Publicado: (2016)

Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population
por: Næss, Sigrid, et al.
Publicado: (2014)

Pregnane-X-Receptor Controls Hepatic Glucuronidation During Pregnancy and Neonatal Development in Humanized UGT1 Mice
por: Chen, Shujuan, et al.
Publicado: (2012)

Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Inhibit Farnesoid X Receptor Resulting in a Cholestatic Phenotype
por: Abu-Hayyeh, Shadi, et al.
Publicado: (2013)

Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+)-taurocholate cotransporting polypeptide knockout mice
por: Slijepcevic, Davor, et al.
Publicado: (2015)

Vitamin D Nuclear Receptor Deficiency Promotes Cholestatic Liver Injury by Disruption of Biliary Epithelial Cell Junctions in Mice
por: Firrincieli, Delphine, et al.
Publicado: (2013)

Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum
por: Abu‐Hayyeh, Shadi, et al.
Publicado: (2015)

Conjugated Bilirubin Triggers Anemia by Inducing Erythrocyte Death
por: Lang, Elisabeth, et al.
Publicado: (2015)

Association of Severe Intrahepatic Cholestasis of Pregnancy With Adverse Pregnancy Outcomes: A Prospective Population-Based Case-Control Study
por: Geenes, Victoria, et al.
Publicado: (2014)

Human intrahepatic regulatory T cells are functional, require IL‐2 from effector cells for survival, and are susceptible to Fas ligand‐mediated apoptosis
por: Chen, Yung‐Yi, et al.
Publicado: (2016)

The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17
por: Waisbourd‐Zinman, Orith, et al.
Publicado: (2016)

Soluble Adenylyl Cyclase Regulates Bile Salt‐Induced Apoptosis in Human Cholangiocytes
por: Chang, Jung‐Chin, et al.
Publicado: (2016)

Cholestasis‐induced adaptive remodeling of interlobular bile ducts
por: Vartak, Nachiket, et al.
Publicado: (2016)

The SRL peptide of rhesus rotavirus VP4 protein governs cholangiocyte infection and the murine model of biliary atresia
por: Mohanty, Sujit K., et al.
Publicado: (2017)

Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ‐glutamyltransferase cholestasis
por: Qiu, Yi‐Ling, et al.
Publicado: (2017)

Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?
por: Chapman, Roger W, et al.
Publicado: (2017)

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Lynch, Kate D., et al.
Publicado: (2019)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
por: Molinaro, Antonio, et al.
Publicado: (2017)

Unique patterns of glycosylation in immunoglobulin subclass G4‐related disease and primary sclerosing cholangitis
por: Culver, Emma L, et al.
Publicado: (2018)

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma
por: Forsbring, Monika, et al.
Publicado: (2009)

Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF‐1
por: Liu, Lei, et al.
Publicado: (2019)

Impact on follow‐up strategies in patients with primary sclerosing cholangitis
por: Bergquist, Annika, et al.
Publicado: (2022)

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis
por: Radford‐Smith, Daniel E., et al.
Publicado: (2022)

Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
por: Dhillon, Amandeep K., et al.
Publicado: (2019)

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
por: Andersen, Ina M., et al.
Publicado: (2015)

Fatigue in primary sclerosing cholangitis is associated with sympathetic over‐activity and increased cardiac output
por: Dyson, Jessica K., et al.
Publicado: (2014)

Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
por: Bossen, Lars, et al.
Publicado: (2021)

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
por: Hov, Johannes R., et al.
Publicado: (2010)

Impact of early cholecystectomy on the readmission rate in patients with acute gallstone cholangitis: a retrospective single-centre study
por: Hoilat, Gilles Jadd, et al.
Publicado: (2021)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
por: Braadland, Peder Rustøen, et al.
Publicado: (2022)

Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis
por: Yoshida, Hiroyuki, et al.
Publicado: (2023)

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2022)

The Simple Cholestatic Complaints Score is a valid and quick patient‐reported outcome measure in primary sclerosing cholangitis
por: van Munster, Kim N., et al.
Publicado: (2020)

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
por: Hole, Mikal Jacob, et al.
Publicado: (2023)

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
por: Vedeld, Hege Marie, et al.
Publicado: (2021)

Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study
por: Hunyady, Peter, et al.
Publicado: (2022)

Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis
por: Giles, Joanna L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6rhdl83rh0i0b306hoaho9ktic